跳至主要内容
临床试验/ACTRN12609000391279
ACTRN12609000391279招募中4 期

Comparative 12 month study of menstrually-signalled use of an ethinyl oestradiol and levonorgestrel low-dose pill and a low-dose contraceptive vaginal ring containing ethinyl oestradiol and etonogestrel to assess the number of bleeding spotting days

Family Planning NSW0 个研究点目标入组 140 人开始时间: 2009年6月1日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Can be new users, restarters or switchers
  • No contraindications to combined hormonal contraceptive use
  • Willing to give informed consent to randomisation
  • Willing to be contacted monthly by research assistant and to maintain a menstrual chart
  • Willing to have a blood samples taken at inclusion and completion of study for biochemical and haematological testing.
  • Willing to keep account of sanitary protection used and cost over duration of study.

排除标准

  • Currently pregnant or trying to get pregnant.
  • Sterilisation.
  • Contraindications to combined hormonal contraceptive use
  • Smokers aged = 35 years and over are excluded
  • Depot medroxyprogestogen acetateuse within last six months
  • Undiagnosed intermenstrual bleeding
  • Problems with cycle control whilst taking combined oral contraceptives leading to discontinuation
  • Unwilling to stop taking non-steroidal anti-inflammatory drugs
  • Taking any concomitant medications which cause enzyme induction and could effect steroidal blood levels

研究者

相似试验

Comparative 12 month study of menstrually-signalled... | 临床试验